[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371603-105":59,"doc-detail-371603-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-clinical-potentials-of-combining-paclitaxel-based-chemotherapy-regimen-with-metformin-in-cancer-treatment-a-systematic-review-and-meta-analysis","The clinical potentials of combining paclitaxel-based chemotherapy regimen with metformin in cancer treatment - A systematic review and Meta-analysis","","Several clinical trials suggest metformin combined with paclitaxel-based chemotherapy may benefit multiple tumors, yet conclusions remain inconsistent. A systematic review and meta-analysis compared paclitaxel plus metformin versus paclitaxel-based chemotherapy alone across indifferent organ neoplasms. Searches in Scopus, PubMed, Web of Sciences, Embase, and Google Scholar up to December 2023 targeted randomized controlled trials. Methodological quality was assessed, and pooled SMD, OR, and 95% CIs were computed using random-effects models.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-clinical-potentials-of-combining-paclitaxel-based-chemotherapy-regimen-with-metformin-in-cancer-treatment-a-systematic-review-and-meta-analysis/371603/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-clinical-potentials-of-combining-paclitaxel-based-chemotherapy-regimen-with-metformin-in-cancer-treatment-a-systematic-review-and-meta-analysis/371603.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the document’s main objective?","Question",{"text":113,"@type":114},"To systematically review and meta-analyze clinical evidence comparing paclitaxel plus metformin versus paclitaxel-based chemotherapy alone in cancer treatment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which study types and sources were used for the analysis?",{"text":118,"@type":114},"Randomized controlled trials were identified via comprehensive searches in Scopus, PubMed, Web of Sciences, Embase, and Google Scholar up to December 2023.",{"name":120,"@type":111,"acceptedAnswer":121},"What outcomes improved with the paclitaxel-metformin combination?",{"text":122,"@type":114},"Overall survival (OS) showed a significant improvement versus paclitaxel alone, and pathological complete response (pCR) showed a borderline significant increase.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},371603,1790378066,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","Translational Oncology 59 (2025) 102438  \nContents lists available at ScienceDirect  \nTranslational Oncology  \njournal [homepage:](homepage: www.elsevier.com/locate/tranon)[ www.elsevier.com/locate/tranon](homepage: www.elsevier.com/locate/tranon)  \n| Review Article\u003Cbr>The clinical potentials of combining paclitaxel-based chemotherapy regimen with metformin in cancer treatment: A systematic review and Meta-analysis |  |  | |\n| --- | --- | --- | --- |\n| Behnam Omidi Sarajara, Nima Rastegar-Pouyania, Azadeh Rasoulia, Fateme Nikbakhtb, Mahdieh Nezami Majdc, Mohammad H. Ghahremania, Seyed Nasser Ostada,\u003Cbr>Emad Jafarzadeha,*, Mohsen Dehghanib,**\u003Cbr>a Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran b Department of Epidemiology, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran\u003Cbr>c Department of Comparative biosciences (CBS), School of Veterinary Medicine, University of Tehran, Tehran, Iran |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Metformin Paclitaxel Combination therapy Chemotherapy Cancer\u003Cbr>Meta-analysis |  | Background: Several clinical trials have shown that combining metformin with paclitaxel-based chemotherapy has a promising effect on various tumors but with inconsistent findings. We conducted a systematic review and meta-analysis to compare the effects of paclitaxel plus metformin versus paclitaxel-based chemotherapy alone indifferent organ neoplasms.\u003Cbr>Methods: A comprehensive literature search was performed in Scopus, PubMed, Web of Sciences, Embase and also Google scholar until December 2023 using MeSH keywords and all similar terms limited to randomized controlled trials (RCTs). The retrieved studies were assessed for methodological quality. Pooled standardize mean difference (SMD), odds ratio (OR) and 95 % confidence intervals (CI) of clinical outcomes were calculated using random-effects meta-analysis.\u003Cbr>Results: Of 921 records, ultimately, 14 RCTs met the criteria for inclusion in the meta-analysis. Based on a metaanalysis findings, combination therapy of a paclitaxel-based regimen with metformin was found to be significantly associated with improved overall survival (OS) compared to the paclitaxel alone in various types of cancers (pooled SMD: 1.27; 95 % CI: 0.10, 2.43). Moreover, the metformin plus paclitaxel showed a borderline significant improvement in the pathological complete response (pCR) rate compared to the paclitaxel alone (Pooled OR: 1.74; 95 % CI: 0.96, 3.15). However, there was no significant improvement in the metformin plus paclitaxel group compared to the paclitaxel group for progression-free survival (PFS) and disease-free survival (DFS).\u003Cbr>Conclusion: The findings indicate that a combination of paclitaxel-based chemotherapy with metformin enhances OS and pCR in cancer patients. This combination therapy has the potential to improve treatment effectiveness and safety. |  |\n\nIntroduction  \nCancer is the second leading cause of death worldwide. Despite recent medical advances, it is still a major health issue [1]. There are several modalities routinely adopted against cancer, including surgery, chemotherapy (monotherapy or combination therapy), radiation therapy, immunotherapy, targeted therapy, and hormonal therapy [2,3];  \nhowever, none can guarantee to solve the menace of cancer for good, which persistently calls for fresh attempts to devise novel anti-cancer approaches.  \nPaclitaxel (PTX) is a natural tetracyclic diterpenoid, belonging to the taxane family, which is extracted from the bark of the yew tree Taxus brevifolia. PTX is a commonly administered anticancer drug for the treatment of different types of cancer [4], such as ovarian cancer, lung  \n* Corresponding authors at: Department of Epidemiology, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.  \n** Corresponding authors at: Department of Toxicology and Pharmacology, Faculty of Pharmacy, ","cbCaicKZEq4A6w7U","https://ap.wps.com/l/cbCaicKZEq4A6w7U","pdf",1640508,"English","# Contents\n## Abstract\n## Introduction","[{\"question\":\"What is the document’s main objective?\",\"answer\":\"To systematically review and meta-analyze clinical evidence comparing paclitaxel plus metformin versus paclitaxel-based chemotherapy alone in cancer treatment.\"},{\"question\":\"Which study types and sources were used for the analysis?\",\"answer\":\"Randomized controlled trials were identified via comprehensive searches in Scopus, PubMed, Web of Sciences, Embase, and Google Scholar up to December 2023.\"},{\"question\":\"What outcomes improved with the paclitaxel-metformin combination?\",\"answer\":\"Overall survival (OS) showed a significant improvement versus paclitaxel alone, and pathological complete response (pCR) showed a borderline significant increase.\"}]","The clinical potentials of combining paclitaxel-based chemotherapy regimen with metformin in cancer treatment - A systematic review and Meta-analysis | PDF",1790192425,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27bab7890e856f15f39eaafeceb7d035.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d3aff7057b111b7bc1c8c1c4f8b16c4.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8832c1a112bf9950c48d3b0d5088a825.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bea34992927e344a664e4033c227c6c.webp",980,1306]